A securities class action has been filed in the USDC – DE. against 3D Systems Corporation (DDD) (“3D Systems” or the “Company”), on behalf of all persons and entities that purchased or otherwise acquired 3D Systems securities between August 13, 2024, and May 12, 2025, both dates inclusive (the “Class Period”).
3D Systems provides 3D printing and digital manufacturing solutions in North and South America, Europe, the Middle East, Africa, the Asia Pacific, and Oceania. The Company earns revenue from the sale of products and services through its two operating segments: Healthcare Solutions and Industrial Solutions. The Healthcare Solutions segment includes dental, medical devices, personalized health services, and regenerative medicine (the “Regenerative Medicine Program”).
The complaint alleges throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that:
(1) 3D Systems had understated the impact of weakened customer spending on the Company’s business, while overstating its resilience in challenging industry conditions;
(2) in addition, the updated milestone criteria in the United Partnership would negatively impact the Company’s Regenerative Medicine Program revenue; and
(3) as a result, the Company’s public statements were materially false and misleading at all relevant times, thereby harming investors.
If you purchased 3D Systems securities during the Class Period and would like to receive more information or join the action, please enter your contact information below for a FREE consultation and click “Submit Your Information”.